Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ammonia N-13 Myocardial Blood Flow Absolute Quantification by Positron Emission Tomography in Patients With Known or Suspected Coronary Artery Disease (Ammonia MAP)

NCT04343209 is registered in ClinicalTrials.gov with Ionetix Corporation as lead sponsor.

NCT NCT04343209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04343209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ammonia N-13 Myocardial Blood Flow Absolute Quantification by Positron Emission Tomography in Patients With Known or Suspected Coronary Artery Disease (Ammonia MAP)
Lead sponsor
Ionetix Corporation
Phase
Observational
Overall status
Completed
Start date
September 14, 2020
Completion date
August 16, 2024
Enrollment
170 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive diseases, arteriosclerosis, cardiovascular diseases, coronary artery disease, coronary disease, heart diseases, myocardial ischemia, vascular diseases